OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MDAI$2.1358

Spectral AI Inc

Advanced Medical Equipment & TechnologyVerified

Spectral AI operates with a cash balance of $15.4 million against $27.1 million in total liabilities, resulting in a negative equity position of $5.7 million. The company's liquidity position is rated as low, with a current ratio of 0.94 and negative free cash flow of $7.5 million in the latest period. The enterprise value to revenue multiple of 3.09 suggests market optimism despite the company's negative EBITDA of $7.57 million. The company's financial performance shows significant underperformance relative to industry norms. With a return on equity of 1.32% and a negative return on assets of -0.35%, Spectral AI lags behind the typical performance metrics for advanced medical equipment firms. The operating margin of -43.8% (calculated from $8.6 million operating loss on $19.7 million revenue) indicates structural cost challenges. Geographically, the company's revenue concentration data is not available in the current dataset. Segmental breakdowns also remain undisclosed, suggesting a lack of transparency in operational diversification. This opacity limits the ability to assess risk distribution across product lines or geographic markets. Looking ahead, the company faces a challenging growth trajectory. With no revenue growth data available and a current operating loss, the outlook for near-term profitability remains uncertain. Analysts have assigned a mean price target of $4.67, implying a 124% upside from the current market price of $2.13, but the absence of disclosed revenue growth metrics makes this target speculative. Risk factors include the company's negative equity position and operating cash flow deficit. The dilution risk is currently rated as low, with no immediate filing-based flags detected. However, the company's capital structure shows a debt-to-equity ratio of -1.47, indicating that liabilities exceed equity by a significant margin. Recent filings and transcripts do not show any material events that would significantly alter the company's risk profile. The absence of recent strategic announcements or product launches suggests a period of operational stability but also limited visibility into future growth drivers.

30-day price · MDAI+0.82 (+55.0%)
Low$1.37High$2.36Close$2.31As of9 May, 00:00 UTC
Profile
CompanySpectral AI Inc
TickerMDAI.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Spectral AI Inc develops and commercializes AI-powered medical imaging solutions for diagnostic and therapeutic applications in healthcare.

Classification. The company is classified in the Healthcare sector under Advanced Medical Equipment & Technology with 92% confidence based on verified market data.

Spectral AI operates with a cash balance of $15.4 million against $27.1 million in total liabilities, resulting in a negative equity position of $5.7 million. The company's liquidity position is rated as low, with a current ratio of 0.94 and negative free cash flow of $7.5 million in the latest period. The enterprise value to revenue multiple of 3.09 suggests market optimism despite the company's negative EBITDA of $7.57 million. The company's financial performance shows significant underperformance relative to industry norms. With a return on equity of 1.32% and a negative return on assets of -0.35%, Spectral AI lags behind the typical performance metrics for advanced medical equipment firms. The operating margin of -43.8% (calculated from $8.6 million operating loss on $19.7 million revenue) indicates structural cost challenges. Geographically, the company's revenue concentration data is not available in the current dataset. Segmental breakdowns also remain undisclosed, suggesting a lack of transparency in operational diversification. This opacity limits the ability to assess risk distribution across product lines or geographic markets. Looking ahead, the company faces a challenging growth trajectory. With no revenue growth data available and a current operating loss, the outlook for near-term profitability remains uncertain. Analysts have assigned a mean price target of $4.67, implying a 124% upside from the current market price of $2.13, but the absence of disclosed revenue growth metrics makes this target speculative. Risk factors include the company's negative equity position and operating cash flow deficit. The dilution risk is currently rated as low, with no immediate filing-based flags detected. However, the company's capital structure shows a debt-to-equity ratio of -1.47, indicating that liabilities exceed equity by a significant margin. Recent filings and transcripts do not show any material events that would significantly alter the company's risk profile. The absence of recent strategic announcements or product launches suggests a period of operational stability but also limited visibility into future growth drivers.
Key takeaways
  • The company maintains a cash buffer of $15.4 million but faces a liquidity risk due to $27.1 million in liabilities.
  • Spectral AI's financial performance lags industry norms with a negative return on assets of -0.35%.
  • Analysts project a mean price target of $4.67, implying a 124% upside from the current market price.
  • The company's capital structure shows a debt-to-equity ratio of -1.47, indicating significant leverage.
  • No immediate dilution or liquidity flags were detected in recent filings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$19.6M
Gross profit$8.9M
Operating income-$8.6M
Net income-$7.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$9.9M
CapEx
Free cash flow-$7.5M
Total assets$21.4M
Total liabilities$27.1M
Total equity-$5.7M
Cash & equivalents$15.4M
Long-term debt$8.4M
Valuation
Market price$2.13
Market cap$67.8M
Enterprise value$60.8M
P/E
Reported non-GAAP P/E
EV/Revenue3.1
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$5.7M
Net cash$7.0M
Current ratio0.9
Debt/Equity-1.5
ROA-35.4%
ROE1.3%
Cash conversion1.3%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricMDAIActivity
Op margin-43.8%-16.5% medp25 -174.5% · p75 8.8%below median
Net margin-38.5%-16.5% medp25 -172.4% · p75 8.4%below median
Gross margin45.4%47.4% medp25 34.2% · p75 65.3%below median
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity-147.0%4.3% medp25 0.0% · p75 28.0%bottom quartile
Observations
IR observations
Mean price target4.67 USD
Median price target5.00 USD
High price target6.00 USD
Low price target3.00 USD
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.48 USD
Last actual EPS-0.29 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 15:44 UTC#9a883b8a
Market quoteclose USD 2.25 · shares 0.03B diluted
no public URL
2026-05-16 15:46 UTC#97f1b4cf
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 12:59 UTCJob: 2854b93d